Product logins

Find logins to all Clarivate products below.


Biopsy Devices | Market Insights | US | 2023

The US biopsy device market was negatively impacted by the COVID-19 pandemic. However, overall biopsy procedure volumes will continue to grow marginally through 2031, driven by favorable demographic trends, the development of more accurate testing methods, improved imaging technologies, as well as updated recommendations to screening guidelines.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biopsy devices in the US from 2019 through 2031.

Related Medtech Insights Reports

Report
Biopsy Devices – Market Insights – Europe (Supplemental)
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – Europe
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – United States
The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…
Report
Small-Joint Reconstructive Implants | Market Insights | Latin America (Supplemental) | 2024
The Latin American small-joint reconstructive implant market is significantly underpenetrated when compared to the US and European markets, providing ample room for expansion. The adoption of…
Report
Pain Management Devices | Medtech Insights | Europe | 2024
Following the recovery from the impact of the COVID-19 pandemic, the European pain management device market will see moderate growth through 2032. Manufacturers in this space are actively…